术后免疫疗法:用于切除的非小细胞肺癌的主要临床治疗方法

Zhijun Yuan1, Mengyuan Yang2,3, Xian Zhong2,3

  • 1Department of Radiation Oncology (Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education, Key Laboratory of Molecular Biology in Medical Sciences, Zhejiang Province, China), The Second Affiliated Hospital Zhejiang University School of Medicine Hangzhou Zhejiang China.

MedComm
|February 29, 2024
PubMed
概括

术后免疫疗法在早期非小细胞肺癌 (NSCLC) 中显示出显著的前景. 第三阶段试验表明,这种方法正在成为切除性NSCLC的关键治疗方法.